Business / Finance

RSS

Bormioli Pharma North America sales grew by more than 40% in 2022

Bormioli Pharma, a global leader partnering with customers to provide comprehensive packaging solutions for injectable drugs, today announced robust growth in its North American business in 2022, with sales increasing more than 40% year-over-year.

From Bormioli Pharma S.p.A. 15 Mar 2023

EVOSEP and ReSyn Biosciences partner to integrate their technologies into new clinical proteomics solutions

The ability to process large and clinically relevant cohorts in a robust and high-throughput manner is important to unlocking the full potential of proteomics for precision medicine.

From Evosep 14 Mar 2023

Veterans’ health administration expands deployment of Mikroscan Systems

Mikroscan Technologies, innovators and manufacturers of live robotic microscopy and whole-slide imaging (WSI) systems, announces that it has expanded its relationship with the Veterans’ Administration through the multi-system sale of its SL5-20 Real-Time Telemicroscopy and Digital Pathology systems.

From Mikroscan Technologies 14 Mar 2023

Decades of substantial U.S. Government investment in mRNA technology paved way for COVID-19 vaccines

Researchers explore the United States public funding for the development of COVID-19 mRNA vaccines.

6 Mar 2023

Festo breaks price/performance barriers with new multi-axis gantry

Festo introduces the EXCL, a multi-axis gantry kit that lowers acquisition, engineering, and assembly costs for automated sample handling and liquid dispensing in laboratory devices.

From Festo Ltd. 2 Mar 2023

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris.

From Five Alarm Bio 28 Feb 2023

Ingenza appoints new Strategic Business Advisor

Ingenza is excited to welcome Dr Mark Chadwick to the team as Strategic Business Advisor. Mark will bring extensive industry expertise to his new position at Ingenza, acquired over 30 years from a variety of roles within small growth companies, covering the areas of biotechnology, drug discovery and drug development.

23 Feb 2023

Life Sciences Innovator Category Winner 2023

Following a rigorous application process, we are proud to announce that Seda have been selected as the UK Life Sciences Innovator Winner 2023 in the Application, Product & Service Design Category.

From Seda Pharmaceutical Development Services 21 Feb 2023

BioEcho receives patent for its EchoLUTION™ technology in the U.S. and Japan

BioEcho announces the grant of two patents for the innovative EchoLUTION™ technology transforming established nucleic acid extraction procedures.

From BioEcho Life Sciences GmbH 17 Feb 2023

Gender pay gap 2023 caused surprise at lab equipment manufacturer KNAUER

In this year's calculation of the gender pay gap for the company KNAUER, the management had expected a value of less than two percent, in line with the development of recent years.

From KNAUER Wissenschaftliche Geräte GmbH 17 Feb 2023

Grenova Introduces Purus Microwell Plate Cleaner at SLAS 2023

Grenova has added Purus to its green technology portfolio, designed to reduce waste and cut costs for labs around the world.

From Grenova 17 Feb 2023

Beckman Coulter Life Sciences presenting at SLAS2023

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will have a full team of dedicated professionals and informative programming at the upcoming Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition.

From Beckman Coulter Life Sciences 16 Feb 2023

Ultima Genomics partners with New England Biolabs® to expand research applications on Ultima Sequencers

Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced a collaboration to develop and enable use of New England Biolabs’ (NEB®) NEBNext® reagents and library preparation kits on Ultima sequencing platforms.

From Ultima Genomics, Inc. 16 Feb 2023

SP Industries rebrands as ATS Life Sciences Scientific Products

SP Industries, Inc., (“Scientific Products”) a leading global provider of fill-finish drug manufacturing solutions, lyophilizers, and laboratory equipment and supplies, is now going to market as ATS Life Sciences Scientific Products.

From ATS Life Sciences Scientific Products 14 Feb 2023

Tecan collaborates with Singular Genomics to take automated NGS library preparation into the future

Tecan has partnered with Singular Genomics to use the turnkey MagicPrep™ NGS system* to create sequencing-ready libraries for the G4™ Sequencing Platform.

From Tecan 13 Feb 2023

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From Complete Genomics 9 Feb 2023

Evonetix closes $24 million USD (£20 million) financing

Funding will enable development of DNA synthesis chip technology to commercial scale.

From Evonetix 7 Feb 2023

Lonza delivers strong 2022 performance with 15.1% CER sales growth and 32.1% CORE EBITDA margin

Lonza has reported sales of CHF 6.2 billion, sales growth of 15.0% AER (15.1% CER), and CHF 2.0 billion CORE EBITDA, resulting in a margin of 32.1%. These robust financial results are driven by strong underlying business performance and a COVID-related sales peak in 2022 which enhanced both sales and margin.

From Lonza 7 Feb 2023

Cerba Research and Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

Cerba Research announced today a Memorandum of Understanding with Teddy Clinical Research Laboratory (Wuxi, China), a preeminent central lab provider covering mainland China, to lay the foundation for an in-depth discussion towards the creation of a Joint Venture.

From Cerba Research 3 Feb 2023

Oncodesign Services looks to the future

As Oncodesign evolves into Oncodesign Services and begins its journey as an independent business, CEO Fabrice Viviani explains his hopes and plans for the company’s future.

From Oncodesign Services 3 Feb 2023